Department of Chemistry, Bharathiar University, Coimbatore 641046, India.
Eur J Med Chem. 2012 Jan;47(1):228-38. doi: 10.1016/j.ejmech.2011.10.046. Epub 2011 Nov 13.
A new class of heterocycles, specifically substituted pyrazolo-, isoxazolo- and pyrimidocyclohepta[b]indoles, has been prepared by condensation of substituted 7-(hydroxymethylene)-7,8,9,10-tetrahydrocyclohepta[b]indol-6(5H)-ones with hydrazine hydrate, hydroxylamine hydrochloride, phenylhydrazine, urea and thiourea, respectively. The structures of the compounds were established by IR, (1)H NMR, (13)C NMR, mass spectral analysis, X-ray diffraction, and the compounds have been screened for in vitro antimicrobial and antimycobacterial against Mycobacterium tuberculosis H37Rv (MTB). Among the compounds screened, five substances were found to have an MIC of 3.12 μg/ml or greater against MTB. Structure-activity relationship (SAR) analyses and in silico drug relevant properties (HBD, HBA, PSA, c Log P, M.wt) confirmed that the compounds are potential lead compounds for future drug discovery studies.
一类新的杂环化合物,特别是取代的吡唑并、异噁唑并和嘧啶并环庚[b]吲哚,是通过取代的 7-(羟亚甲基)-7,8,9,10-四氢环庚[b]吲哚-6(5H)-酮分别与水合肼、盐酸羟胺、苯肼、尿素和硫脲缩合得到的。化合物的结构通过 IR、(1)H NMR、(13)C NMR、质谱分析、X 射线衍射确定,并且对化合物进行了体外抗微生物和抗分枝杆菌(结核分枝杆菌 H37Rv,MTB)的筛选。在所筛选的化合物中,有五种物质对 MTB 的 MIC 值为 3.12μg/ml 或更高。结构-活性关系(SAR)分析和计算机药物相关性质(HBD、HBA、PSA、c Log P、M.wt)证实,这些化合物是未来药物发现研究的潜在先导化合物。